These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 580135)

  • 21. Free insulin profiles in insulin-dependent diabetics treated with one or two insulin injections per day.
    Olsson PO; Arnqvist H; von Schenck H
    Acta Med Scand; 1986; 220(2):133-41. PubMed ID: 3535391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin binding and free insulin in serum of insulin-treated diabetics.
    Lev-Ran A; Ratt L
    Horm Metab Res; 1973 Mar; 5(2):67-70. PubMed ID: 4707702
    [No Abstract]   [Full Text] [Related]  

  • 23. [C-peptide and insulin in diabetics].
    Zhonghua Yi Xue Za Zhi; 1982 Nov; 62(11):651-6. PubMed ID: 6819875
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients.
    Sakata S; Matsuda M; Komaki T; Miura K
    Immunol Invest; 1987 May; 16(3):263-71. PubMed ID: 3311984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of free, total, and antibody-bound insulin in insulin-treated diabetics.
    Gennaro WD; Van Norman JD
    Clin Chem; 1975 Jun; 21(7):873-9. PubMed ID: 236845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects.
    Sebriakova M; Little JA
    Diabetes; 1973 Jan; 22(1):30-40. PubMed ID: 4734254
    [No Abstract]   [Full Text] [Related]  

  • 27. Diurnal profiles of serum insulin, C-peptide and blood intermediary metabolites in insulin treated diabetics, their relationship to the control of diabetes and the role of endogenous insulin secretion.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Binder C; Faber OK
    Q J Med; 1979 Apr; 48(190):343-60. PubMed ID: 574299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unrecognised nocturnal hypoglycaemia in insulin-treated diabetics.
    Gale EA; Tattersall RB
    Lancet; 1979 May; 1(8125):1049-52. PubMed ID: 86775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.
    Gardner DF; Wilson HK; Podet EJ; Arakaki RF; Nell LJ; Thomas JW; Crane MM; Field JB
    J Clin Endocrinol Metab; 1986 Apr; 62(4):621-7. PubMed ID: 3512590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diurnal growth hormone and glucose abnormalities in unstable diabetics: studies of ambulatory-fed subjects during continuous blood glucose analysis.
    Molnar GD; Taylor WF; Langworthy A; Fatourechi V
    J Clin Endocrinol Metab; 1972 May; 34(5):837-46. PubMed ID: 5012495
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical effects of monocomponent insulin and commercial insulin preparations on insulin requiring diabetics (author's transl)].
    Nakashima Y; Oyama H; Tenku A; Matsumura S; Nishida S
    Radioisotopes; 1977 Mar; 26(3):158-62. PubMed ID: 578932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free insulin, bound insulin, C-peptide and the metabolic control in juvenile onset diabetics: comparison of C-peptide secretors and non-secretors during 24 hours conventional insulin therapy.
    Gerbitz KD; Kemmler W; Edelmann A; Summer J; Mehnert H; Wieland OH
    Eur J Clin Invest; 1979 Dec; 9(6):475-83. PubMed ID: 119646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic rhythms in normal and diabetic man. Studies in insulin-treated diabetes.
    Alberti KG; Dornhorst A; Rowe AS
    Isr J Med Sci; 1975 Jun; 11(6):571-80. PubMed ID: 1158666
    [No Abstract]   [Full Text] [Related]  

  • 35. Determination of free and antibody-bound insulin in insulin treated diabetic patients.
    Heding LG
    Horm Metab Res; 1969 May; 1(3):145-6. PubMed ID: 5408729
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma immunoreactive insulin patterns in insulin-treated diabetics. Studies during continuous blood glucose monitoring.
    Molnar GD; Taylor WF; Langworthy AL
    Mayo Clin Proc; 1972 Oct; 47(10):709-19. PubMed ID: 4635563
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of the insulin antibody titre in severe form of diabetes mellitus].
    Pliats OM; Alekseev IuP
    Probl Endokrinol (Mosk); 1977; 23(3):12-4. PubMed ID: 887624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin antibodies do not influence the absorption rate of subcutaneously injected insulin.
    de Meijer PH; Lutterman JA; van't Laar A
    Diabet Med; 1988 Nov; 5(8):776-81. PubMed ID: 2975571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of free and total insulin in insulin-treated diabetics].
    Wójcikowski C
    Endokrynol Pol; 1976; 27(1):63-70. PubMed ID: 1253761
    [No Abstract]   [Full Text] [Related]  

  • 40. Total insulin levels in type 1 diabetic patients with insulin antibodies and their effect on insulin requirement and metabolic control.
    Hübinger A; Becker A; Gries FA
    Diabetes Res; 1988 Feb; 7(2):65-9. PubMed ID: 3293878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.